ライフサイエンスコーパス: Nurses' Health Study

1 from Europe (ESTHER) and the United States (Nurses' Health Study).

2 Health Professionals Follow-Up Study and the Nurses' Health Study.

3 years of follow-up from 1989 to 2004 in the Nurses' Health Study.

4 ls not using postmenopausal hormones) in the Nurses' Health Study.

5 -up among 107 130 members of the prospective Nurses' Health Study.

6 Study, the Multiethnic Cohort Study, and the Nurses' Health Study.

7 ident lung cancers among 78,612 women in the Nurses' Health Study.

8 cognitive function among older women in the Nurses' Health Study.

9 ticipated in two case-control studies in the Nurses' Health Study.

10 nals Follow-Up Study and 53,772 women in the Nurses' Health Study.

11 TL among 7,813 women aged 43-70 years in the Nurses' Health Study.

12 risk of FI among postmenopausal women in the Nurses' Health Study.

13 72,719 women (age, 40-73 y) enrolled in the Nurses' Health Study.

14 opausal breast cancer in 86,621 women in the Nurses' Health Study.

15 24 y of follow-up in women with CVD from the Nurses' Health Study.

16 history of hypertension or diabetes from the Nurses' Health Study.

17 bjects (n = 549 each) were selected from the Nurses' Health Study.

18 c mortality among 50,112 participants in the Nurses' Health Study.

19 The analysis was conducted within the Nurses' Health Study.

20 study among participants of the female-only Nurses' Health Study.

21 in 1504 women of European ancestry from the Nurses' Health Study.

22 S women with type 2 diabetes mellitus in the Nurses' Health Study.

23 or to RA symptoms (preclinical RA), from the Nurses' Health Study.

24 with RCC risk among 118,219 US women in the Nurses' Health Study.

25 their relationship to cardiac events in the Nurses' Health Study.

26 the Health Professionals Follow-up Study and Nurses' Health Study.

27 enoid levels and mammographic density in the Nurses' Health Study.

28 cancer risk among 83,767 participants in the Nurses' Health Study.

29 ls Follow-up Study and 71,243 women from the Nurses' Health Study.

30 pigmentation among 49,323 white women in the Nurses' Health Study.

31 studies, including among 1,982 women in the Nurses' Health Study.

32 orted hearing loss among 55,850 women in the Nurses' Health Study.

33 m healthy 50-60-year-old participants in the Nurses' Health Study.

34 with benign breast disease according to the Nurses' Health Studies.

35 2010-2012), conducted among subgroups of the Nurses' Health Studies.

36 e large and independent prospective cohorts: Nurses' Health Study 1 (n = 88,540), Nurses' Health Stud

37 nsumed <250 mg/d were 0.89 (0.83 to 0.96) in Nurses' Health Study 1, 1.02 (0.91 to 1.14) in Nurses' H

38 fructose intake were 1.02 (0.99 to 1.06) in Nurses' Health Study 1, 1.03 (0.98 to 1.08) in Nurses' H

39 h amyotrophic lateral sclerosis (ALS) in the Nurses' Health Study (1976-2004), the Health Professiona

40 ioid, and mucinous ovarian cancers in the US Nurses' Health Study (1976-2006) and Nurses' Health Stud

41 By using 2 case-control GWAS (the Nurses' Health Study, 1976-2006, and the Health Professi

42 The authors included 76,364 women from the Nurses' Health Study (1980 to 2012), 92,946 women from t

43 ated in a nested case-control study from the Nurses' Health Study (1980-2002) and the Health Professi

44 uals in 2 US nationwide prospective cohorts (Nurses' Health Study (1980-2008) and Health Professional

45 50,151 women and men aged >/=20 years in the Nurses' Health Study (1980-2008), the Nurses' Health Stu

46 specific mortality among 76,464 women in the Nurses' Health Study (1980-2010) and 42,498 men in the H

47 Two large US prospective cohort studies, the Nurses' Health Study (1980-2010) and Health Professional

48 ne/threonine kinase (BRAF), mutation) in the Nurses' Health Study (1980-2010) and the Health Professi

49 We followed 80,978 women from the Nurses' Health Study (1980-2012) and 39,434 men from the

50 We followed 84,628 women (Nurses' Health Study, 1980 to 2010), and 42,908 men (Hea

51 We used data on 87,166 women in the Nurses' Health Study (1982-2010) and 32,959 men in the H

52 A total of 63,810 women in the Nurses' Health Study (1984 to 2010) and 41,622 men in th

53 prospectively followed 71,141 women from the Nurses' Health Study (1984-2008) and 42,135 men from the

54 prospectively followed 74,248 women from the Nurses' Health Study (1984-2008), 90,411 women from the

55 in and incident T2D in 72,992 women from the Nurses' Health Study (1984-2008), 92,088 women from Nurs

56 ing a questionnaire in 70,842 women from the Nurses' Health Study (1984-2010) and 40,789 men from the

57 207,556 women and men [73,228 women from the Nurses' Health Study (1984-2010), 92,158 women from the

58 We collected data from the Nurses' Health Study (1984-2012) and Health Professional

59 We included 69,949 women from the Nurses' Health Study (1984-2012), 90,239 women from the

60 We included 73,710 women in NHS (Nurses' Health Study) (1984 to 2012), 92,329 women in NH

61 participants from a U.S. female cohort, the Nurses' Health Study (1986-2006), and a U.S. male cohort

62 dy (1988-2008), 72,231 women enrolled in the Nurses' Health Study (1986-2008), and 90,836 women enrol

63 860 women (7,582 breast cancer cases) in the Nurses' Health Study (1988-2004) and Nurses' Health Stud

64 data from 2 prospective cohort studies, the Nurses' Health Study (1988-2012; n = 78,516) and Nurses'

65 ding 1,528 cases and 2,844 controls from the Nurses' Health Study (1989-2004) and Nurses' Health Stud

66 tudy (1994 to 2008) and 144 women within the Nurses' Health Study (1990 to 2010) with incident confir

67 Using data from 52,110 women in the Nurses' Health Study (1990), we reproduced the cross-sec

68 omen aged 32-70 years at blood draw from the Nurses' Health Study (1990-2006) and Nurses' Health Stud

69 rticipants from a cohort of older women (the Nurses' Health Study, 1996-2008), a cohort of younger wo

70 in the Nurses' Health Study (1980-2008), the Nurses' Health Study 2 (1989-2009), and the Health Profe

71 lth Study (1984-2012), 90,239 women from the Nurses' Health Study 2 (1991-2011), and 40,539 men from

72 ohorts: Nurses' Health Study 1 (n = 88,540), Nurses' Health Study 2 (n = 97,315), and the Health Prof

73 atitis (AD) and cardiovascular events in the Nurses' Health Study 2, a cohort of US women.

74 rses' Health Study 1, 1.03 (0.98 to 1.08) in Nurses' Health Study 2, and 0.99 (0.93 to 1.05) in Heath

75 rses' Health Study 1, 1.02 (0.91 to 1.14) in Nurses' Health Study 2, and 1.06 (0.97 to 1.15) in Healt

76 itis (AD) in a large cohort of US women, the Nurses' Health Study 2.

77 se with CVD events among 66 798 women in the Nurses' Health Study 2.

78 haracterized cohort studies of US women: the Nurses' Health Study (2000-2010) and Nurses' Health Stud

79 ly in a nested case-control study within the Nurses' Health Study [218 melanoma, 285 squamous cell ca

80 th in a nested case-control study within the Nurses' Health Study: 218 melanoma cases, 285 squamous-c

81 tudies of diabetic patients: the prospective Nurses' Health Study (309 CHD cases, and 544 control sub

82 The study evaluated 1922 women from the Nurses' Health Study (62% of whom were overweight) who h

83 biennially in the prospective cohorts of the Nurses' Health Study (63 893 women; 1984-2012) and the H

84 participants with incident diabetes from the Nurses' Health Study (8970 participants) and Health Prof

85 trol analysis within the 121,700-participant Nurses' Health Study, 99 cases of definite or probable S

86 ciations with IGF-axis protein levels in the Nurses' Health Study, a cohort of middle-aged women.

87 y, 74,886 women 38 to 63 years of age in the Nurses' Health Study, a cohort study of female nurses, w

88 For participants in the Nurses' Health Study, a nationwide prospective cohort of

89 (EPA)'s Air Toxics tract-level data with the Nurses' Health Study, a prospective cohort of female nur

90 Using data from the Nurses' Health Study, a prospective cohort study of 51,3

91 lected in 1989-1990 from participants of the Nurses' Health Study, a study of nurses from 11 US state

92 In the Nurses' Health Study, a US prospective cohort study span

93 ore than 20 years of follow-up data from the Nurses' Health Study (all female registered nurses) and

94 The Nurses' Health Study, an ongoing cohort study of registe

95 We used data from the Nurses' Health Study, an ongoing nationwide prospective

96 Participants (49 033 women in the Nurses Health Study and 20 066 men in the Health Profess

97 We followed 75 889 women from the Nurses' Health Study and 38 961 men from the Health Prof

98 and eight hundred eighty-nine women from the Nurses' Health Study and 38,961 men from Health Professi

99 n clinical follow-up of 109,046 women in the Nurses' Health Study and 47,684 men in the Health Profes

100 ) activity in 853 female participants of the Nurses' Health Study and 878 male participants of the He

101 23 female nurses for 24 y (1986-2010) in the Nurses' Health Study and estimate the relative risk of b

102 wed up, from 1984 until May 31, 2010, in the Nurses' Health Study and from 1986 until January 31, 201

103 7 nondiabetic CHD-negative controls from the Nurses' Health Study and Health Professionals Follow-up

104 In an analysis data from the Nurses' Health Study and Health Professionals Follow-up

105 (VTE) among 129,430 US women and men in the Nurses' Health Study and Health Professionals Follow-up

106 ional study within two large US cohorts: the Nurses' Health Study and Health Professionals Follow-Up

107 n 96,000 white postmenopausal women from the Nurses' Health Study and men aged 50 years and older fro

108 tosus among 184,643 US women followed in the Nurses' Health Study and Nurses' Health Study II cohorts

109 In an analysis of data from the Nurses' Health Study and the Health Professionals Follow

110 through June 2012) among participants in the Nurses' Health Study and the Health Professionals Follow

111 l participants of European ancestry from the Nurses' Health Study and the Health Professionals Follow

112 than is an intake in the recent past in the Nurses' Health Study and the Health Professionals Follow

113 atients with rectal or colon cancer from the Nurses' Health Study and the Health Professionals Follow

114 Using data from the Nurses' Health Study and the Health Professionals Follow

115 and 4564 men from 2 prospective cohorts: The Nurses' Health Study and the Health Professionals Follow

116 PATIENTS: Two US prospective cohort studies (Nurses' Health Study and the Health Professionals Follow

117 In the Nurses' Health Study and the Health Professionals Follow

118 and parental smoking during childhood in the Nurses' Health Study and the Health Professionals Follow

119 spective cohort study, with cohorts from the Nurses' Health Study and the Health Professionals Follow

120 2272 in RBP4 in independent samples from the Nurses' Health Study and the Invecchiare in Chianti Stud

121 measured in blood collected in 1989 to 1990 (Nurses' Health Study) and 1993 to 1994 (Health Professio

122 ovided prediagnosis blood specimens in 1990 (Nurses' Health Study) and 1994 (Health Professionals' Fo

123 Blood samples were collected in 1989-1990 (Nurses' Health Study) and 2000-2002 (ESTHER).

124 sionals) from June 1, 1980, to May 31, 2010 (Nurses' Health Study) and January 1, 1986, to December 3

125 ion Study that was conducted within the NHS (Nurses' Health Study) and NHS II longitudinal cohorts.

126 dy among women of European ancestry from the Nurses' Health Study, and identified genome-wide signifi

127 cases matched 1:1 to controls (from the NHS [Nurses' Health Study]) and in a replication cohort of 2,

128 spective cohort study of 44,636 women in the Nurses' Health Study, associations of abdominal adiposit

129 ge range: 50-77 y) without depression in the Nurses' Health Study at baseline (1996) who were followe

130 aged 30 to 55 years who participated in the Nurses' Health Study, attendance at religious services o

131 In the Nurses' Health Study, bowel movement frequency was self-

132 s conducted in postmenopausal women from the Nurses' Health Study cohort (n = 73,572).

133 Professionals Follow up Study (HPFS) and the Nurses' Health Study cohort (NHS) additive and multiplic

134 w-up was completed on June 30, 2012, for the Nurses' Health Study cohort and January 31, 2010, for th

135 eveloped CHD and 472 matched controls in the Nurses' Health Study cohort during 16 years of follow-up

136 In independent validation data (Nurses' Health Study cohort) the breast and ovarian canc

137 sted in the Physicians' Health Study and the Nurses' Health Study cohorts to determine whether patter

138 These methods are applied to Nurses' Health Study data from 1980-2006, during which 3

139 ional study of 105,986 women enrolled in the Nurses' Health Study followed up from 1980 until 2008 wi

140 ed up over 26 years, who participated in the Nurses' Health Study, followed up for 3,317,425 person-y

141 incident diabetes case-control pairs in the Nurses' Health Study, for whom levels of plasma fetuin-A

142 and three hundred and sixty-two women in the Nurses' Health Study, free of CHD and stroke at baseline

143 in postmenopausal women (n = 121,700) in the Nurses' Health Study from 1980-2010.

144 Mammography information was available in the Nurses' Health Study from 1988, and 1,815 incident breas

145 ctive cohort study of 81,722 US women in the Nurses' Health Study from June 1984 to June 2010.

146 viduals with MS and 281 controls from the US Nurses' Health Studies I and II (NHS/NHS II), for whom w

147 Study (n = 45,821 men; 18 yr of follow-up), Nurses' Health Study I (n = 94,108 older women; 18 yr of

148 d 40-75 years; follow-up from 1986 to 2010), Nurses' Health Study I (NHS I) (90,235 women aged 30-55

149 Nurses' Health Study I and II and Health Professionals F

150 3,587 nondiabetic women in 2 US cohorts, the Nurses' Health Study I in 2000 and the Nurses' Health St

151 in the Nurses' Health Study (1988-2004) and Nurses' Health Study II (1989-2005) who recalled their b

152 the US Nurses' Health Study (1976-2006) and Nurses' Health Study II (1989-2005).

153 nd subsequent CHD among 116 430 women in the Nurses' Health Study II (1989-2009).

154 es' Health Study (1988-2012; n = 78,516) and Nurses' Health Study II (1989-2013; n = 114,559), we exa

155 Study (1980 to 2012), 92,946 women from the Nurses' Health Study II (1991 to 2013), and 41,526 men f

156 -control study nested within the prospective Nurses' Health Study II (1991-2001).

157 We included 95,809 women from Nurses' Health Study II (1991-2005).

158 Health Study (1984-2008), 92,088 women from Nurses' Health Study II (1991-2009) and 40,722 men from

159 lth Study (1984-2008), 90,411 women from the Nurses' Health Study II (1991-2009), and 40,498 men from

160 lth Study (1984-2010), 92,158 women from the Nurses' Health Study II (1991-2011), and 42,170 men from

161 dy (1986-2008), and 90,836 women enrolled in Nurses' Health Study II (1993-2007).

162 rom the Nurses' Health Study (1989-2004) and Nurses' Health Study II (1996-2003).

163 rom the Nurses' Health Study (1990-2006) and Nurses' Health Study II (1997-2005).

164 en: the Nurses' Health Study (2000-2010) and Nurses' Health Study II (1997-2007).

165 d ASD in the children of participants in the Nurses' Health Study II (325 cases, 22,101 controls).

166 We included the subsample of the Nurses' Health Study II (54 224 participants; ages 24-44

167 tudy ([NHS] aged 53-81 years, 2000-2008) and Nurses' Health Study II ([NHSII] aged 36-55 years, 2001-

168 00) and 52,587 women aged 29-46 years in the Nurses' Health Study II (in 1993-2001).

169 h ASD and 17,728 comparison mothers from the Nurses' Health Study II (index births in 1991-2007).

170 94,108 older women; 18 yr of follow-up), and Nurses' Health Study II (n = 101,837 younger women; 14 y

171 dies-the Nurses' Health Study (n = 121,701), Nurses' Health Study II (n = 116,686), and Health Profes

172 -55 years; follow-up from 1992 to 2010), and Nurses' Health Study II (NHS II) (106,122 women aged 25-

173 -59 years (1980-2006) and 100,547 women from Nurses' Health Study II (NHS II) aged 26-46 years (1991-

174 ed case-control study of participants in the Nurses' Health Study II (NHS II), a prospective cohort o

175 m the Nurses' Health Study (NHS; 1989-2010), Nurses' Health Study II (NHS II; 1996-2009), and the Wom

176 idence of early menopause in the prospective Nurses' Health Study II (NHS2).Intakes of vitamin D and

177 en in a case-control study nested within the Nurses' Health Study II (NHSII).

178 cholesterolemia among 69 505 US women in the Nurses' Health Study II (NHSII; 1991-2011).

179 idential location and ASD in the children of Nurses' Health Study II (United States) participants in

180 The Nurses' Health Study II ascertained lifetime trauma expo

181 among 40,773 eligible pregnancies in the US Nurses' Health Study II cohort (1989-2001).

182 In a case-control study nested within the Nurses' Health Study II cohort, we measured the concentr

183 ce using data from the nationwide U.S.-based Nurses' Health Study II cohort.

184 men followed in the Nurses' Health Study and Nurses' Health Study II cohorts in 1980-2004.

185 2001, 35,794 mothers of participants of the Nurses' Health Study II completed a questionnaire inquir

186 DES exposure and incident UL in women in the Nurses' Health Study II from 1989 to 2009.

187 , the Nurses' Health Study I in 2000 and the Nurses' Health Study II in 1997.

188 with breast cancer among 45,204 women in the Nurses' Health Study II using reduced rank regression.

189 ssion was assessed among participants in the Nurses' Health Study II who first reported their history

190 followed 93,835 US women aged 27-44 years in Nurses' Health Study II who had alcohol consumption data

191 risk factors from 13,864 participants in the Nurses' Health Study II who had completed a self-adminis

192 women ages 27 to 44 years at baseline in the Nurses' Health Study II who were followed from 1991 to 2

193 ts in the NHS (Nurses' Health Study), NHSII (Nurses' Health Study II), and Health Professionals Follo

194 , 1996-2008), a cohort of younger women (the Nurses' Health Study II, 1991-2005), and a cohort of men

195 ional analysis of 49,408 participants in the Nurses' Health Study II, a cohort comprising women nurse

196 Participants were drawn from the Nurses' Health Study II, a cohort of 116,430 female nurs

197 Data were from the Nurses' Health Study II, a prospective cohort study.

198 The Nurses' Health Study II, a prospective observational stu

199 The Nurses' Health Study II, a US longitudinal cohort of wom

200 ses' Health Study (NHS), 93,054 women in the Nurses' Health Study II, and 40,557 men in the Health Pr

201 In an analysis of data from the Nurses' Health Study II, we did not observe a convincing

202 Among participants in the Nurses' Health Study II, who were younger than participa

203 weeks) and CVD in 70 182 parous women in the Nurses' Health Study II.

204 f exposure with risk of endometriosis in the Nurses' Health Study II.

205 nancy with this child as part of the ongoing Nurses' Health Study II.

206 life among 19,771 women participating in the Nurses' Health Study II.

207 irmed endometriosis among 70,556 US women in Nurses' Health Study II.

208 women aged 31-48 years at baseline (1995) in Nurses' Health Study II.

209 ohort study of 55,636 parous women in the US Nurses' Health Study II.

210 risk among 90,628 premenopausal women in the Nurses' Health Study II.

211 -control study nested within the prospective Nurses' Health Study II.

212 molecule-1) in 524 middle-aged women in the Nurses' Health Study II.

213 -control study nested within the prospective Nurses' Health Study II.

214 d their mothers, who are participants in the Nurses' Health Study II.

215 over a 20-year period in 49 978 women in the Nurses' Health Study II.

216 is in a case-control study nested within the Nurses' Health Study II.

217 luated this possibility in a substudy of the Nurses' Health Study II.

218 ts of the Nurses' Health Study (NHS) and the Nurses' Health Study-II (NHS-II) over 24 and 16 years of

219 re collected from 32 826 participants of the Nurses' Health Study in 1989-1990, among whom 146 incide

220 ollowed 52,682 women aged 46-71 years in the Nurses' Health Study (in 1992-2000) and 52,587 women age

221 n a large, long-term prospective cohort, the Nurses' Health Study, in an analysis that included 89708

222 ctive cohort study among 41,844 women in the Nurses' Health Study, in the United States.

223 hort study was conducted using data from the Nurses' Health Study (June 1, 1980, to June 1, 2012) and

224 Based on data from the Nurses' Health Study, long-term intake of dietary fiber,

225 dults in 3 national, prospective studies-the Nurses' Health Study (n = 121,701), Nurses' Health Study

226 drawn from the two independent studies: the Nurses' Health Study (n = 1590) and the Health, Aging an

227 We used prospective data from the Nurses' Health Study (n = 70,021).

228 rofessionals Follow-up Study (HPFS), and the Nurses Health Study (NHS).

229 althy women followed up over 24 years in the Nurses' Health Studies (NHS [1988-2012]: N = 73,623 and

230 In the Nurses' Health Study (NHS) (enrolling during 1980-1994 a

231 971 incident T2D case-control pairs from the Nurses' Health Study (NHS) (mean age, 65.6 years) and NH

232 ividuals of European ancestry drawn from the Nurses' Health Study (NHS) (N = 1,591).

233 intake.We evaluated associations within the Nurses' Health Study (NHS) (n = 88,598) and the Health P

234 mellitus (T2DM) among 101,415 women from the Nurses' Health Study (NHS) aged 34-59 years (1980-2006)

235 We followed 78,977 women from the Nurses' Health Study (NHS) and 41,202 men from the Healt

236 followed 59,930 women aged 37-65 y from the Nurses' Health Study (NHS) and 85,157 women aged 26-45 y

237 sectional data from 5013 participants in the Nurses' Health Study (NHS) and Health Professionals Foll

238 ers) and obesity risk in 6934 women from the Nurses' Health Study (NHS) and in 4423 men from the Heal

239 /=10 (distant) years before diagnosis in the Nurses' Health Study (NHS) and NHSII with breast cancer

240 incidence among 197,486 participants of the Nurses' Health Study (NHS) and the Nurses' Health Study-

241 (HPFS) during 2000-2006 (33,901 men) and the Nurses' Health Study (NHS) during 1982-2006 (93,767 wome

242 sk of incident stroke in 86,149 women in the Nurses' Health Study (NHS) I and 94,715 women in the NHS

243 93 600 women 25 to 42 years of age from the Nurses' Health Study (NHS) II who were healthy at baseli

244 en in a genome-wide association study in the Nurses' Health Study (NHS) NCI-Cancer Genetic Markers of

245 Beginning in 1980, Nurses' Health Study (NHS) participants completed dietar

246 specific mortality among 74,890 women in the Nurses' Health Study (NHS), 93,054 women in the Nurses'

247 Women's Health across the Nation (SWAN), the Nurses' Health Study (NHS), and the Rancho Bernardo Stud

248 predict type 2 diabetes mellitus (T2DM): the Nurses' Health Study (NHS), European Prospective Investi

249 udy of three prospective cohort studies: the Nurses' Health Study (NHS), NHSII, and the Women's Healt

250 controls within the all-female cohort of the Nurses' Health Study (NHS).

251 rofessionals Follow-up Study (HPFS), and the Nurses' Health Study (NHS).

252 lth Professionals Follow-Up Study (HPFS) and Nurses' Health Study (NHS).

253 included from an older cohort of women (the Nurses' Health Study (NHS); 1996-2008), a younger cohort

254 prospectively observed 74,749 women from the Nurses' Health Study (NHS, 1984-2008) and 39,059 men fro

255 o traits in a total of 17,438 women from the Nurses' Health Study (NHS, N = 2,287) and the Women's Ge

256 ls Follow-up Study (HPFS; 1986-2002) and the Nurses' Health Study (NHS; 1980-2002).

257 in prospectively collected samples from the Nurses' Health Study (NHS; 1989-2010), Nurses' Health St

258 identified and confirmed among women in the Nurses' Health Study (NHS; 1990-2006) and among men in t

259 breast cancer of European ancestry from the Nurses' Health Study (NHS; P = 0.006); the association w

260 le-aged and older women for 8 years from the Nurses' Health Study ([NHS] aged 53-81 years, 2000-2008)

261 omen (the Women's Health Study [WHS] and the Nurses' Health Study [NHS]).

262 e collected in 3168 participants in the NHS (Nurses' Health Study), NHSII (Nurses' Health Study II),

263 623 US healthy, postmenopausal women in the Nurses' Health Study not using exogenous hormones at the

264 the Health Professionals Follow-up Study and Nurses' Health Study, of whom 732 developed CVD.

265 00, cognitive function was assessed in 1,550 Nurses' Health Study participants aged > or =70 years wi

266 Nurses' Health Study participants responded to a questio

267 RESEARCH DESIGN AND Of 32,826 Nurses' Health Study participants who provided blood sam

268 Participants were 617 Nurses' Health Study participants with K-shell X-ray flu

269 stionnaire was administered every 4 years to Nurses' Health Study participants.

270 s to evaluate this issue prospectively among Nurses' Health Study participants.

271 As part of the prospective Nurses' Health Study, participants biennially reported t

272 Using data from the U.S.-based Nurses' Health Study prospective cohort, we defined cumu

273 A dataset from the Nurses' Health Study served as a replication cohort.

274 n (mean age, 65 +/- 7 years) enrolled in the Nurses' Health Study since 2000 and 28,989 men (mean age

275 risk of CHD in women who participated in the Nurses' Health Study, taking into account the duration o

276 analyzes cancer and lifestyle data from the Nurses' Health Study, the Health Professionals Follow-up

277 his study, we used data from the prospective Nurses' Health Study to evaluate whether the association

278 the Health Professionals Follow-up Study and Nurses' Health Study using multivariable-adjusted Cox pr

279 m 1980-2010 for 90,286 women enrolled in the Nurses' Health Study, we performed competing-risks regre

280 ancer samples from 1,841 participants in the Nurses' Health Study were scored for levels of nuclear H

281 (mean age, 73 years) who participated in the Nurses' Health Study, were enrolled since 2008, and with

282 ective cohort study of 71 531 women from the Nurses' Health Study who completed a validated dietary q

283 dult women aged 27 to 44 years in the second Nurses' Health Study who did not have hypertension, card

284 to June 1, 2008) of 77 728 US women from the Nurses' Health Study who provided biennially updated dat

285 s from 4,164 female registered nurses in the Nurses' Health Study who were diagnosed with stages I, I

286 asthma in 76,470 asthma-free women from the Nurses' Health Study who were followed between 1988 and

287 pression risk among 32,900 US women from the Nurses' Health Study who were free from depressive sympt

288 analysis involving 49,821 US women from the Nurses' Health Study who were free from depressive sympt

289 udy among 119,332 women participating in the Nurses' Health Study who were free of cardiovascular dis

290 n 2002 in a cohort of 46,289 US women in the Nurses' Health Study who were free of T2D, cardiovascula

291 We included 13,818 women from the Nurses' Health Study with dietary data and no major chro

292 owed 84,136 women aged 30 to 55 years in the Nurses' Health Study with no known cancer, diabetes mell

293 conducted a nested case-control study in the Nurses' Health Study, with 1,506 invasive breast cancer

294 edian age, 54 years) enrolled in 1976 in the Nurses' Health Study without a prior history of CD or UC

295 ded 52,135 women (mean age: 44.2 y) from the Nurses' Health Study without chronic diseases in 1980 an

296 a prospective cohort of 83,076 women in the Nurses' Health Study without history of stroke, coronary

297 SCD among 101 018 women participating in the Nurses' Health Study without known coronary heart diseas

298 We included a subset of 78,980 Nurses' Health Study women and 41,221 Health Professiona

299 ples were collected from 1989 to 1990 in the nurses' health study (women) and from 1993 to 1995 in th

300 In the Nurses' Health Study, women with 30 years or more of shi